EPS
Earnings per share, a key profitability metric.
Latest EPS: $8.26 (2026Q1); +169.9% YoY.
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Cumulative FCF
Shares Outstanding
Rule of 40
Quarterly EPS Data
| Period | Value |
|---|---|
| 2024Q1 | $2.48 |
| 2024Q2 | $3.28 |
| 2024Q3 | $1.07 |
| 2024Q4 | $4.88 |
| 2025Q1 | $3.06 |
| 2025Q2 | $6.29 |
| 2025Q3 | $6.21 |
| 2025Q4 | $7.39 |
| 2026Q1 | $8.26 |
Healthcare Comparison
1 / 3
Other LLY Charts
More quarter-by-quarter fundamentals for Eli Lilly and Company
1 / 8